MXPA03010055A - Analogos de 17-metileno-androstan-3a-ol como inhibidores de hlc. - Google Patents

Analogos de 17-metileno-androstan-3a-ol como inhibidores de hlc.

Info

Publication number
MXPA03010055A
MXPA03010055A MXPA03010055A MXPA03010055A MXPA03010055A MX PA03010055 A MXPA03010055 A MX PA03010055A MX PA03010055 A MXPA03010055 A MX PA03010055A MX PA03010055 A MXPA03010055 A MX PA03010055A MX PA03010055 A MXPA03010055 A MX PA03010055A
Authority
MX
Mexico
Prior art keywords
3alpha
androstan
analogs
methylene
crh
Prior art date
Application number
MXPA03010055A
Other languages
English (en)
Inventor
L Berliner David
Original Assignee
Pherin Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pherin Pharm Inc filed Critical Pherin Pharm Inc
Publication of MXPA03010055A publication Critical patent/MXPA03010055A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Los analogos de 17-metileno-androstan-3a-ol son utiles como inhibidores de hormona liberadora de corticotropina (HLC), y especialmente como antidepresivos, cuando se administran al organo vomeronasal. Se describe una sintesis de 17-metiIenoandrost-4-en-3a -ol.
MXPA03010055A 2001-05-03 2002-04-26 Analogos de 17-metileno-androstan-3a-ol como inhibidores de hlc. MXPA03010055A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/848,247 US20030045514A1 (en) 2001-05-03 2001-05-03 17-Methyleneandrostan-3alpha-ol analogs as CRH inhibitors
PCT/US2002/013255 WO2002089814A1 (en) 2001-05-03 2002-04-26 17-METHYLENE-ANDROSTAN-3α-OL ANALOGS AS CRH INHIBITORS

Publications (1)

Publication Number Publication Date
MXPA03010055A true MXPA03010055A (es) 2004-04-02

Family

ID=25302777

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03010055A MXPA03010055A (es) 2001-05-03 2002-04-26 Analogos de 17-metileno-androstan-3a-ol como inhibidores de hlc.

Country Status (8)

Country Link
US (2) US20030045514A1 (es)
EP (1) EP1392320B1 (es)
JP (1) JP2004528364A (es)
CA (1) CA2484596A1 (es)
DE (1) DE60217480T2 (es)
ES (1) ES2278962T3 (es)
MX (1) MXPA03010055A (es)
WO (1) WO2002089814A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1789056A1 (en) * 2004-06-29 2007-05-30 Jado Technologies GmbH Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts
MX2010011063A (es) * 2008-04-09 2010-11-22 Pherin Pharm Inc Tratamiento esteroidal para sofocos.
PE20091929A1 (es) * 2008-05-21 2010-01-09 Gruenenthal Chemie Procedimientos para la sintesis selectiva del acetato de 3alfa-hidroxicloromadinona
CN103347525A (zh) * 2010-12-15 2013-10-09 哈博生物科学公司 制备3α-氧取代的甾族化合物的方法及化合物
HUE051938T2 (hu) 2011-05-20 2021-03-29 Inst Nat Sante Rech Med CB1 receptor antagonisták
AU2013351190B2 (en) 2012-11-28 2018-03-29 Alienor Farma 3-(4'-substituted)-benzyl-ether derivatives of pregnenolone
AU2013371025B2 (en) 2012-12-28 2018-01-18 Pherin Pharmaceuticals, Inc. Use of pregn-4-en-20-yn-3-one for the treatment of depressive disorders
US10729693B2 (en) * 2018-03-02 2020-08-04 Ponce Medical School Foundation, Inc. Compositions and methods for the treatment of endometriosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
US5563131A (en) * 1994-08-04 1996-10-08 Pherin Corporation Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5994333A (en) * 1994-08-04 1999-11-30 Pherin Corporation Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US6057439A (en) * 1994-08-04 2000-05-02 Pherin Corporation Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
GB9626746D0 (en) * 1996-12-23 1997-02-12 Knoll Ag Process

Also Published As

Publication number Publication date
ES2278962T3 (es) 2007-08-16
WO2002089814A1 (en) 2002-11-14
DE60217480T2 (de) 2007-10-25
US20030045514A1 (en) 2003-03-06
JP2004528364A (ja) 2004-09-16
US20030220309A1 (en) 2003-11-27
EP1392320A1 (en) 2004-03-03
CA2484596A1 (en) 2002-11-14
DE60217480D1 (de) 2007-02-22
EP1392320B1 (en) 2007-01-10

Similar Documents

Publication Publication Date Title
GEP20074078B (en) Fluoro substituted cyclo-alkanoindoles, compositions comprising them and their use
MXPA05001061A (es) Composiciones farmaceuticas, acuosas de 2,6-diisopropilfenol.
BRPI0417684A (pt) composto, composição farmacêutica, e, uso de um composto
WO2003103603A3 (en) NEW FORMIATE-TYPE SALT OF O-DESMETHYLVENLAFAXINE
TNSN07235A1 (en) Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
UY27465A1 (es) Métodos y composiciones para tratar flavivirus y pestivirus con 4' modificaciones nucleosides
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
AU7743001A (en) Cyclopentanoindoles, compositions containing such compounds and methods of treatment
MXPA05002942A (es) Forma de dosificacion oral de liberacion modificada.
AU8645401A (en) Substituted pyrazoles
ATE423562T1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
TW200605863A (en) Bazedoxifene acetate formulations
EG23185A (en) Active compound combinations having insecticidal and acaricidal properties.
EP1755388A4 (en) MIXED CO-CRYSTALS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
MXPA03010055A (es) Analogos de 17-metileno-androstan-3a-ol como inhibidores de hlc.
AP2002002427A0 (en) Ppar compounds.
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
DK1414467T3 (da) Topisk behandling af mastalgi
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
DK1401279T3 (da) Acaricidpulver
TW200706173A (en) Oral composition comprising carbamylating agent
WO2003073988A3 (en) Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof
MXPA05012655A (es) Isomeros puros d-(17a)-13 -etil-17-hidroxi -18, 19-dinorpregn- 4-eno-20-ino -3-ona-3e -y ??3z- oxima, asi como el proceso para la sintesis de la mezcla de isomeros y los isomeros puros.
ATE364619T1 (de) Tibolonformulierungen
WO2003070177A3 (en) Use of melatonin analogues for induction of general anesthesia

Legal Events

Date Code Title Description
FG Grant or registration